Does Zinc Shorten the Common Cold?

Apurv Research
Apurv Research · Medical Evidence Review
2026-06-10 · Connor Research Swarm · MEDICAL
Confidence 7/10📚 31 primary sources

The Question

Does zinc supplementation shorten the duration of the common cold — and if so, in what form, at what dose, and started when?

−2.4 days
The 2024 Cochrane review found zinc may cut cold duration by ~2.4 days when used for treatment — but the evidence is highly heterogeneous (I²=97%) and it does not prevent colds.
33%
shorter cold at ≥75 mg/day (7 RCTs)
I²=97%
between-study heterogeneity — weak certainty
RR 1.34
more non-serious adverse events vs placebo

Executive Summary

The honest answer is a qualified, conditional yes — zinc can shorten a cold, but only as a treatment started at onset, in lozenge form, at an adequate dose, and the certainty of evidence is low. The pivotal 2024 Cochrane review (Nault et al., 34 studies, 8,526 participants) found zinc may reduce mean cold duration by about 2.37 days when used therapeutically, but with extreme heterogeneity (I²=97%) that forces a low-certainty grade, and many included trials had industry ties or undisclosed funding. The more consistent signal comes from Hemilä’s lozenge meta-analyses: doses of ≥75 mg/day of elemental zinc shortened colds by ~33% (95% CI 21–45%), with zinc acetate lozenges (~40%) modestly outperforming gluconate (~28%) — plausibly because acetate releases more free ionic zinc in the pharyngeal mucosa. Crucially, zinc does not prevent colds (prophylaxis shows little to no benefit), oral tablets/syrup lack the local mucosal effect of lozenges, and intranasal zinc is unsafe (the FDA-flagged Zicam nasal products were recalled for anosmia). The trade-off is real: zinc treatment raises non-serious adverse events (nausea, dysgeusia/metallic taste; RR 1.34), though serious harms are absent and copper depletion only occurs with prolonged excess. Bottom line: a high-dose zinc acetate lozenge within ~24h of onset is a reasonable, low-cost option for shortening a cold — not for preventing one — with eyes open about modest, uncertain benefit and a metallic aftertaste.
  1. The 2024 Cochrane systematic review (Nault et al.) analyzed 34 studies (15 prevention, 19 treatment) involving 8,526 participants conducted in 13 countries.Conf 9/10[Nault, Cochrane, Salon]
  2. For cold treatment, zinc may reduce mean cold duration by 2.37 days (MD −2.37; 95% CI −4.21 to −0.53; I² = 97%; 8 studies, 972 participants), rated as low-certainty evidence by GRADE.Conf 9/10[Nault, Cochrane]
  3. Zinc showed little or no reduction in the risk of developing a cold, mean annual number of colds, or symptom severity when used for prevention.Conf 9/10[Nault, Cochrane, Salon]
  4. Zinc treatment was associated with an increased risk of non-serious adverse events (RR 1.34; 95% CI 1.15 to 1.55), with no serious side effects rated as moderate-certainty evidence.Conf 9/10[Nault, Cochrane]
  5. Nausea, vomiting, and dysgeusia (metallic taste) are the most common adverse effects associated with oral zinc formulations for cold treatment.Conf 9/10[Memorial Sloan Kettering Cancer Center, Pharmacy Times, American Family Physician (AAFP)]
  6. Most studies included in the Cochrane review were funded by organizations with ties to related commerce/industry or did not report their funding source.Conf 7/10[Nault, Cochrane]
  7. An earlier IPD meta-analysis (Hemilä & Chalker, 2017, OFID, 3 RCTs) found that zinc acetate lozenges may increase the recovery rate from common cold, suggesting formulation-specific effects that the 2024 Cochrane review did not separately analyze.Conf 7/10[PubMed Central / BMJ Open, Open Forum Infectious Diseases (Oxford Academic)]
  8. Zinc lozenges containing ≥75 mg/day elemental zinc shortened common cold duration by 33% on average (95% CI 21%–45%) across 7 randomized placebo-controlled trials (Hemila 2017 meta-analysis).Conf 7/10[University of Helsinki (press release for Hemilä 2017), CMAJ (Canadian Medical Association Journal)]
  9. Zinc acetate lozenges shortened cold duration by 40% (3 trials) while zinc gluconate lozenges shortened duration by 28% (4 trials), a difference that was not statistically significant between formulations (Hemila 2017).Conf 7/10[University of Helsinki (press release for Hemilä 2017), PMC / Therapeutics and Clinical Risk Management]
  10. In the 2024 Cochrane review (Nault et al.), zinc treatment shortened cold duration by MD −2.37 days (95% CI −4.21 to −0.53), but with I²=97% heterogeneity and rated as low-certainty evidence across 8 studies (972 participants).Conf 7/10[PMC / Therapeutics and Clinical Risk Management, Cochrane]
  11. There is no evidence that zinc lozenge doses higher than 100 mg/day of elemental zinc produce greater cold-duration benefits than doses of 80–92 mg/day; no dose-response gradient has been demonstrated above the 75 mg/day threshold.Conf 7/10[PMC / Therapeutics and Clinical Risk Management, University of Helsinki (press release for Hemilä 2017)]
  12. Zinc acetate binds zinc ions less tightly than zinc gluconate, releasing more free ionic zinc in the oral/pharyngeal mucosa, which is hypothesized to explain its slightly higher efficacy (42% vs 20% reduction in high-dose IPD meta-analysis), though head-to-head trials show no significant difference.Conf 7/10[PMC / Therapeutics and Clinical Risk Management, University of Helsinki (press release for Hemilä 2017)]
  13. Zinc sulfate administered as oral tablets (not lozenges) has not demonstrated consistent cold-duration benefit in meta-analyses; the positive evidence for zinc cold treatment is concentrated in lozenge formulations of zinc acetate and zinc gluconate, not oral zinc sulfate.Conf 7/10[CMAJ (Canadian Medical Association Journal), PMC / Therapeutics and Clinical Risk Management]
  14. Zinc-induced copper deficiency occurs only after excessive intake over a prolonged period and is easily corrected by adjusting zinc and copper intake; it is not a risk with short-course (10–14 day) therapeutic zinc supplementation.Conf 7/10[IZiNCG (International Zinc Nutrition Consultative Group), StatPearls]
  15. Zinc supplementation above the UL in well-nourished pregnant and lactating women is contraindicated; WHO recommends zinc supplementation for pregnant women only in the context of rigorous research, not routine supplementation.Conf 7/10[American Family Physician (AAFP), World Health Organization]
  16. The same Cochrane review found that prophylactic zinc supplementation may make little to no difference in preventing colds (9 studies, 1449 people) and probably makes little to no difference to cold length if caught (3 studies, 740 participants).Conf 7/10[Cochrane]
  17. The Cochrane review found that zinc used for cold treatment probably increases the risk of non-serious adverse events compared to placebo, with irregularities in taste (dysgeusia) and stomach upset being the most commonly reported.Conf 7/10[Cochrane, Mayo]
Zinc Acetate Lozengesthe best-supported form
Best evidence Hemilä IPD meta-analyses (2017 OFID; 2015)
Effect ~40% shorter cold duration (3 trials)
Dose ≥75 mg/day elemental zinc; >100 mg/day adds no benefit
Mechanism binds zinc loosely → more free ionic zinc in pharyngeal mucosa
Timing therapeutic, started at symptom onset
⚠ Benefit is for TREATMENT only — zinc does not prevent colds. Non-serious adverse events (nausea, metallic taste) increase (RR 1.34).
Verdict. The form with the strongest, most consistent duration benefit. A high-dose acetate lozenge at onset is the evidence-backed choice.
Zinc Gluconate Lozengescommon OTC form
Effect ~28% shorter duration (4 trials)
vs acetate modestly less effective; binds zinc more tightly
Dose same ≥75 mg/day elemental zinc threshold
Verdict. Works, but acetate edges it out. Either is reasonable; dose and timing matter more than the salt.
Oral Tablets / Syrup & Intranasalwhat NOT to rely on
Oral zinc sulfate tablets no consistent duration benefit in meta-analyses (lacks local mucosal contact)
Intranasal zinc (Zicam) FDA-flagged; nasal swabs recalled (anosmia/loss of smell)
Prophylactic daily zinc little to no effect on preventing colds (Cochrane, 9 studies)
⚠ Avoid intranasal zinc entirely (smell loss). Don’t expect systemic tablets/syrup to match lozenges.
Verdict. Lozenges deliver zinc where it acts (throat); systemic and nasal routes don’t — skip them for colds.

Cold-duration reduction by zinc form (%)

Cochrane 2024 — what zinc does vs doesn't

When does zinc actually help?

Zinc for prevention and treatment of the common cold - NaultConf 9/10
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.cd014914.pub2/full
Systematic review · ✓ Clean No COI
Zinc for prevention and treatment of the common cold - CochrConf 9/10
https://pmc.ncbi.nlm.nih.gov/articles/PMC11078591/
Systematic review · ✓ Clean No COI
Shortcomings in the Cochrane review on zinc for the common cConf 8/10
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1470004/full
RCT / journal · ✓ Clean No COI
Cochrane: Zinc may help shorten common cold, but more evidenConf 6/10
https://www.cidrap.umn.edu/cochrane-zinc-may-help-shorten-common-cold-more-evidence-needed
Press · ✓ Clean No COI
Zinc lozenges and the common cold: a meta-analysis comparingConf 8/10
https://pmc.ncbi.nlm.nih.gov/articles/PMC5418896/
RCT / journal · ✓ Clean No COI
Zinc Acetate Lozenges May Improve the Recovery Rate of CommoConf 8/10
https://academic.oup.com/ofid/article/4/2/ofx059/3098578
RCT / journal · ✓ Clean No COI
Does zinc actually prevent and shorten colds? Here's why we Conf 6/10
https://www.salon.com/2024/12/18/does-zinc-actually-prevent-and-shorten-colds-heres-why-we-still-dont-know/
Press · ✓ Clean No COI
Zinc for the prevention and treatment of the common cold (CoConf 9/10
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001364.pub4/full
Systematic review · ✓ Clean No COI
Zinc for the treatment of the common cold: a systematic reviConf 9/10
https://www.cmaj.ca/content/184/10/E551
Systematic review · ✓ Clean No COI
Zinc for prevention and treatment of the common cold — formuConf 9/10
https://pmc.ncbi.nlm.nih.gov/articles/PMC8543785/
Systematic review · ✓ Clean No COI
Zinc for prevention and treatment of the common cold (CochraConf 9/10
https://pubmed.ncbi.nlm.nih.gov/38719213/
Systematic review · ✓ Clean No COI
Common cold duration is shortened similarly by zinc acetate Conf 6/10
https://www.helsinki.fi/en/news/healthier-world/common-cold-duration-shortened-similarly-zinc-acetate-and-zinc-gluconate-lozenges
Press · ✓ Clean No COI
Zinc — Health Professional Fact SheetConf 8/10
https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/
Gov / official · ✓ Clean No COI
Zinc for prevention and treatment of the common cold (Nault Conf 9/10
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014914.pub2/full
Systematic review · ✓ Clean No COI
Zinc Acetate Lozenges May Improve the Recovery Rate of CommoConf 8/10
https://pmc.ncbi.nlm.nih.gov/articles/PMC5410113/
RCT / journal · ✓ Clean No COI
Duration and Severity of Symptoms…Patients Treated with ZiConf 8/10
https://academic.oup.com/jid/article/197/6/795/919193
RCT / journal · ✓ Clean No COI
Zinc for the common cold—not if, but when (Hemilä, 2011 editConf 8/10
https://pmc.ncbi.nlm.nih.gov/articles/PMC3273967/
RCT / journal · ✓ Clean No COI
The effectiveness of high dose zinc acetate lozenges on commConf 8/10
https://link.springer.com/article/10.1186/s12875-015-0237-6
RCT / journal · ✓ Clean No COI
Zinc: Prophylaxis and Treatment for the Common Cold (2024)Conf 8/10
https://www.researchgate.net/publication/382019482_Zinc_Prophylaxis_and_Treatment_for_the_Common_Cold
RCT / journal · ✓ Clean No COI
Zinc Deficiency - StatPearls - NCBI BookshelfConf 9/10
https://www.ncbi.nlm.nih.gov/books/NBK493231/
Systematic review · ✓ Clean No COI
Zinc requirements and the risks and benefits of zinc supplemConf 8/10
https://www.sciencedirect.com/science/article/abs/pii/S0946672X06000411
RCT / journal · ✓ Clean No COI
Zinc: An Essential MicronutrientConf 9/10
https://www.aafp.org/afp/2009/0501/p768
Systematic review · ✓ Clean No COI
Zinc | Memorial Sloan Kettering Cancer CenterConf 9/10
https://www.mskcc.org/cancer-care/integrative-medicine/herbs/zinc
Systematic review · ✓ Clean No COI
Zinc supplementation during pregnancyConf 8/10
https://www.who.int/tools/elena/interventions/zinc-pregnancy
Gov / official · ✓ Clean No COI
Low Risk of Adverse Effects from Zinc SupplementationConf 9/10
https://izincg.squarespace.com/s/Low-Risk-of-Adverse-Effects-from-Zinc-Supplementation.pdf
Systematic review · ✓ Clean No COI
The Natural Way to Fight ColdsConf 6/10
https://www.pharmacytimes.com/view/the-natural-way-to-fight-colds
Press · ✓ Clean No COI
Zinc for the prevention and treatment of the common cold — CConf 9/10
https://www.cochrane.org/evidence/CD014914_zinc-prevention-and-treatment-common-cold
Systematic review · ✓ Clean No COI
Cochrane Blogshot: Does zinc help prevent or treat the commoConf 9/10
https://www.usz.ch/en/cochrane-blogshot-does-zinc-help-prevent-or-treat-the-common-cold/
Systematic review · ✓ Clean No COI
Church & Dwight Co. Voluntary Recall — Zicam Cold Remedy NasConf 8/10
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/church-dwight-co-inc-issues-voluntary-nationwide-recall-zicamr-cold-remedy-nasal-swabs-zicamr-nasal
Gov / official · ✓ Clean No COI
Zinc for colds — Mayo Clinic Expert FAQConf 8/10
https://www.mayoclinic.org/diseases-conditions/common-cold/expert-answers/zinc-for-colds/faq-20057769
Gov / official · ✓ Clean No COI
Can zinc shorten your cold? Here's how to take it the right Conf 6/10
https://www.washingtonpost.com/wellness/2025/12/09/zinc-cold-virus-remedy/
Press · ✓ Clean No COI

Audit: 1 audit passes · 31 sources · 2 flagged · 1 contradictions resolved

Transparency appendix — pruned / dropped

Item Reason
The pooled effect on cold duration has extremely high heterogeneity (I² = 97%), which Hemi below-confidence-floor 0.35 (0.342)
Hemilä et al. (2024) contend that the Cochrane review’s adverse effects analysis is mislea below-confidence-floor 0.35 (0.342)
Oral zinc formulations reduced cold symptom duration in adults by 2.63 days in a meta-anal below-confidence-floor 0.35 (0.342)
The NIH Office of Dietary Supplements sets the Tolerable Upper Intake Level (UL) for zinc below-confidence-floor 0.35 (0.342)
The tolerable upper intake level (UL) for elemental zinc in adults is 40 mg/day; chronic i below-confidence-floor 0.35 (0.342)
Doses above 50 mg/day may cause gastrointestinal adverse effects including nausea, abdomin below-confidence-floor 0.35 (0.342)
In over 8,500 children across short-course zinc supplementation trials (5–45 mg/day for di below-confidence-floor 0.35 (0.342)
Zinc lozenges should not be taken for more than 14 days because zinc, as a trace metal, ca below-confidence-floor 0.35 (0.342)